Baird Medical Investment Holdings Ltd Ordinary ShareBDMD
About: Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.
Employees: 143
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.15% more ownership
Funds ownership: 0.86% [Q4 2024] → 1.01% (+0.15%) [Q1 2025]
0% more funds holding
Funds holding: 6 [Q4 2024] → 6 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
18% less capital invested
Capital invested by funds: $1.99M [Q4 2024] → $1.64M (-$352K) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for BDMD.
Financial journalist opinion
